BMS Focuses On Driving Future Growth As Revlimid Generic Launches Near

Opdivo, Eliquis Rise From Year-Ago Quarter, But Down From Q2

 
• By Mandy Jackson
  
Business investment growth concept with abstract arrows on building
Total third quarter revenue of $11.6bn was up 10% from Q3 2020 • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip